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1. Introduction 
1.1 Definition of ultrasonographic method 
Ultrasound exploration (ultrasonography) is a very common diagnostic method. It is part of 
imaging procedures, without using ionizing radiations but ultrasounds (US) with usual 
frequencies of 2 - 5 - 12 MHz. Ultrasounds cross biological environments and are reflected at 
the demarcation limit between structures of different consistencies. The current procedure 
of ultrasound examination called "scanning" is based on the analysis of every plane from a 
region of interest in the human body. Each plane contains a high number of points with 
different brightness (within the limit of the gray scale used by the equipment) and their sum 
makes a defining "echostructure" for each organ. Ultrasound diagnosis is based on changes 
in tissue density due to pathological changes, resulting in echostructure transformation. 
Ultrasonography is an anatomical, hemodynamic and functional exploration. 
1.2 Brief history 
Since the 1940s there have been pioneers (physicians, biologists, physicists) who intuited 
that acoustic energy, at that time used only in war industry to detect submarines, could have 
applications in medical diagnosis. The first ultrasound images contained information about 
the density of tissues displayed along an axis ("A- mode" ultrasound). Later, "sectional" 
ultrasound was invented, which detailed echoes in a plane ("B-mode" ultrasound with 
applications in obstetrics). In the '60s the procedure had an accelerated development by 
diversifying examination techniques, identifying more clinical applications and increasing 
access to a large number of specialties. In the ‘70s clinical specialties such as obstetrics and 
cardiology "claimed" the method, using as the main argument its clinical character arising 
from the direct relationship between the examining physician and the patient. After the ‘90s, 
emergency physicians requested the presence of miniature, portable ultrasound equipment 
in the emergency room proving that ultrasound, using accordingly well defined algorithms, 
contributed to saving lives. Today, ultrasonography is used by clinicians in more than 50% 
of cases. Although there is still an ongoing "battle" between clinicians and radiologists for 
the monopoly over the ultrasound method, the final outcome is an exceptional dynamic of 
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the method, considered today the most common diagnostic imaging procedure in the world 
(Derchi & Claudon, 2009). In the near future the ultrasound examination will be 
unrestrictedly generalized with the introduction of the procedure as basic training for 
medical students, as part of clinical examination. 
1.3 Advantages and disadvantages of the ultrasound method 
Ultrasound is useful for the practitioner as a first imaging procedure in direct correlation to 
the clinical examination. The method has a very good cost/quality ratio, the image is very 
accurate and precise and the information has a dynamic character ("real time imaging"). It is 
important to note that ultrasound has its limitations which the examining physician must 
take into account. Thus, the ultrasound image contains a number of artifacts and is mainly 
limited by phenomena such as US attenuation related to distance and density. Ultrasound is 
an operator-dependent method, thus its reproducibility is reduced. 
1.4 Ultrasound techniques and procedures 
The principles of ultrasonography are complex. The US picture is generated by ultrasound 
penetration into the human body. US are reflected as echoes and converted by the 
transducer into signals. The ultrasound image is multimodal. There are multiple US 
procedures systematized into "clinical applications" and the information obtained is tissular 
("morphometric" type) and vascular ("hemodynamic "type). Finally, US examination is a 
“real time” procedure which reflects the movements of the organs.  It is mandatory to 
connect the US information to the clinical and functional-biochemical data in order to obtain 
the final diagnosis.  
1.4.1 Tissue investigation 
The conventional US currently used in practice is called “2D, gray scale” sonography. The 
technique is based on US property with frequencies > 20 kHz and constant acoustic power 
to cross tissues with an average speed of 1540 cm/sec. US are returned with different 
acoustic power at a variable timeframe depending on the acoustic density of the crossed 
environment and on the position of the reflecting element. There is a proportional 
relationship between the intensity of the echo and the density of a crossed biological 
environment; therefore, ultrasound is a noninvasive tissue density assessment procedure. 
There are two categories of echoes according to their frequency: basic (similar to the incident 
beam, i.e. 3 MHz) and "harmonic" (multiples of the emission frequency, i.e. 6 MHz). 
Harmonic echoes arise from the non-linear vibration of the tissues. Due to their high 
frequency, the result is a high quality image. Harmonic ultrasound technique ("coded 
harmonics" or "tissue harmonic imaging," THI) combined with the pulse inversion 
procedure ("pulse inversion harmonic imaging") allows to obtain information regardless of 
the depth where the region of interest lies and is available on most commercial equipment 
(Choudhry et al, 2000). 
Image resolution (minimum size at which a reflected structure is distinctly shown on the 
screen) is essential for tumor detection. The number of crystals included into the transducer 
and the nominal frequency of the ultrasound beam (the higher the frequency the better the 
resolution) also contribute to the ultrasound image quality. The gain of echoes ("gain" 
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function) and the time compensation of echoes gain ("time gain compensation" function) 
measured in decibels, image depth and the number of focuses, echoes acquisition and their 
representation rate are other elements that allow information rendering with the same 
quality at an approximate ultrasound penetration of 20 to 25 cm. All these phenomena 
contribute to image the tissue echostructure. The sonography has a very good capacity to 
discriminate lesions depending on their consistency (a parenchymal cyst is detectable at a 2-
3 mm size!; a solid nodule is distinctly shown at sizes of  5 - 6 mm). In addition, the method 
allows accurate assessment of the lesion size and the evaluation of organ motility 
(gastrointestinal tract, heart, main vessels). 
The ultrasound image is planar, two-dimensional (2D ultrasound). In recent years 
equipments have been developed, allowing 3D reconstruction of ultrasound images. The 
resulting images are not planes but volumes that can be static (3D) or dynamic (4D). 3D/4D 
exploration has recognized obstetrical applications but other areas of application of this 
method have been identified in recent years, mainly in oncology. 3D/4D ultrasound 
provides accurate information in connection with the space, shape, size and tumors texture. 
This procedure may be useful to measure the real tumor volume as well as the healthy 
surrounding parenchyma which should to be removed in case of surgery. Combining this 
procedure with intratumoral circulation assessment methods allows more accurate 
diagnosis of the tumor nature (Badea et al, 2007). 
1.4.2 Blood flow and microcirculation investigation 
Blood flow can be explored by ultrasound using various techniques. Some are based  
on Doppler principle (or derivatives) and others on the use of intravenous contrast agents 
(CA). 
1.4.2.1 Doppler ultrasound 
It is an established method for the assessment of blood flow based on the frequency 
variation of a US beam hitting a target (in our case, groups of red blood cells) in motion. The 
difference in frequency and its positive or negative character are elements that allow 
vectorial representation of blood speed and direction of movement against the transducer. 
Doppler ultrasound has several technical options: spectral and color coded, each of them 
with their advantages and disadvantages. Thus: spectral ultrasound describes the flow type 
(arterial or venous) and allows measurements. Color flow mode (CFM) ultrasound encodes 
speed vectors related to red blood cells groups thus detecting blood flows. Evaluation of 
tumor vasculature will be made first using the CFM module and then spectral Doppler 
module by positioning the Doppler sample on reference regions. On CFM investigation 
tumor vessels have tortuous paths, aberrant spatial ramifications, they intercommunicate 
and can abruptly end in "glove finger" (Cherrington et al, 2000). Spatial positioning of 
intratumoral vessels can also be illustrated by 3D/4D reconstruction procedures and 
quantitative assessment can be achieved with techniques using color pixel count per unit 
area. Spectral investigation measurements into the tumor vessels lumen show either low 
values (RI<0.65; S/D <2.5) suggesting the absence of arterial precapillary sphincter and the 
presence of arterio-venous shunts or high values secondary to increased interstitial pressure. 
Accelerated flow speed can be identified in the input vessels from the tumor hilum 
suggesting a circulatory bed avid for blood (Cosgrove & Eckersley, 1997). 
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1.4.2.2 Contrast Enhanced Ultrasound (CEUS) 
The introduction of intravenous (i.v.) contrast agents (CAs) is a great step forward for 
ultrasound. The first attempts to contrast ultrasound emerged in the '60s and had 
applications in interventional cardiology. After the 90s, first generation contrast agents were 
introduced into the clinical practice (the most used product is Levovist, Schering AG). These 
are air containing microbubbles, wrapped in a stabilizing membrane with the property to 
enhance the intensity of the echoes received from the blood flow thus making the Doppler 
signal more evident. This type of CAs has the disadvantage of a "blooming” effect of the 
color on CFM examination which masks the information derived from the microcirculation. 
With the development of transducer technology and the introduction of intermittent pulses 
emission with high mechanical index (MI> 0.2) it was possible to detect slow flows by 
identifying signals resulting from "breaking" microbubbles. This technique, called 
"destructive" contrast ultrasound is similar to that of contrast CT or MRI. Its disadvantage is 
that information cannot be obtained in "real time". After the year 2000, second generation 
contrast agents were introduced in clinical practice [SonoVue® in Europe, SonazoidTM in 
Japan, Definity in Canada, OptisonTM). They consist of microbubbles filled with different 
gases other than air, with stability and elasticity in the bloodstream higher than that of the 
first generation CAs. The exposure of these CAs to low mechanical index (MI <0.1 to 0.2) US 
generates harmonics echoes resulting from non linear microbubble oscillation (table 1). 
 
Particularity Importance 
They do not cross vessel walls, being 
strictly confined to the circulatory 
bed.  
They are real angiospecific tracers useful for 
quantification of circulation in a region of 
interest. 
Characterized by repeated 
recirculation from the large to small 
circulation until complete clearance 
High persistence and prolonged investigation 
Elimination of contrast agent is made 
through respiration and breakage 
Can be used in renal and hepatic failure 
They show a non-linear oscillation 
when exposed to low MI ultrasounds  
Ultrasound information is found in harmonic 
echoes  
Ultrasound exploration is dynamic, “in real 
time” 
Table 1. Characteristics of second generation contrast agents. Particularities and importance. 
As low acoustic power US are used, this procedure does not break the microbubbles, which 
allows "real time" blood flow examination during several minutes (Burns & Wilson, 2006). 
Harmonic contrast US examination, using second generation CAs requires special software 
equipment which suppresses 2D ultrasound image derived from the tissues by inverted 
phase ultrasound emission (the technique is called "pulse inversion"). In this way the 
information on the screen will correlate only to harmonic echoes generated by the 
microbubbles (Burns et al, 2000). 
CEUS examination is a qualitative examination. As it is a continuous exploration, CEUS 
allows successive identification of vascular phases: arterial (approximately 10 - 15 sec. from 
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the time of injection in the peripherals up to approx. 30-40 seconds) and venous. Some 
circulation areas (liver, spleen) have a "late" phase due to the "capture" of microbubbles into 
the reticulo-histiocyte system (RHS). In addition, the investigation also allows the 
assessment of vascular morphology which provides information similar to angiography. 
CEUS investigation has a high temporal resolution, superior to CT or MRI explorations. 
CEUS liver investigation has two important elements that make it distinct (Cosgrove, 2007; 
Claudon et al, 2008): 
a. the liver has a complex vascularization: for input (arterial and portal phase, the first  
can be identified in approx. 10 - 30 seconds after injection and the second in approx.  
30 - 90 seconds after i.v. CA injection) and for elimination (sinusoidal phase, 
progressively occurs in approx. 120 seconds after injection and has a total duration of 
approx. 4-5 minutes); 
b. liver tumors have a characteristic vasculature according to their nature, e.g. 
hepatocellular carcinoma is highly arterialized; metastases have a mixed input 
vasculature; benign tumors have a variable circulatory bed (hemangioma is highly 
capillarized). Tumor characterization using CEUS procedure is based on the contrast 
agent crossing the region of interest (dynamic, particularities) and on the vascular bed 
characteristics (presence, spatial distribution, vascular morphology, areas lacking signal 
which means scar or necrosis). This analysis is separately carried out in the arterial, 
portal venous and late phases. Algorithms are currently available that help liver mass 
discrimination (Bolondi et al, 2007). The procedure can be combined with 3D 
reconstruction techniques, which confers additional utility to the method (Luo et al, 
2009). 
A useful procedure to obtain more quantitative details is contrast curves analysis. These 
consist of graphical representation of the CA dynamics while crossing a region of interest. 
The method is useful for assessing chemotherapy efficacy in various malignancies. 
 
Fig. 1. Contrast dynamic analysis curves in the region of interest - TIC. Tracer dynamics in 
the region of reference is marked with blue and with yellow in the region of interest 
(tumor). It can be seen that the tumor has a more abundant circulation than the surrounding 
liver parenchyma. 
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Limitations of CEUS examination. Harmonic contrast examination has some limitations 
including: a) the procedure is indicated only correlated with good 2D image; b) it has a 
relatively high cost; c) it is operator dependent examination. 
2. 2D and harmonic ultrasonography in detecting and characterizing liver 
tumors 
2.1 Characteristics of ultrasound diagnosis 
Ultrasound diagnosis of liver tumors involves two stages: detection and characterization.  
Tumor detection is based on the performance of the method as already presented and should 
include morphometric information (three axes dimensions, volume) and topographic 
information (number, location specifying liver segment and lobe/lobes). The specification of 
these data is important for staging liver tumors and prognosis.  
Tumor characterization is a complex process based on a sum of criteria leading towards 
tumor nature definition. Often, other diagnostic procedures, especially interventional ones 
are no longer necessary. Ultrasound examination has the same morphological and 
hemodynamic criteria as those of CT and MRI imaging procedures. However, semiology 
will be adjusted to the specifics of this method. Tumor characterization using the ultrasound 
method will be based on the following elements: consistency (solid, liquid, mixed), 
echogenity, structure appearance (homogeneous or heterogeneous), delineation from 
adjacent liver parenchyma (capsular, imprecise), elasticity, posterior acoustic enhancement 
effect, the relation with neighboring organs or structures (displacement, invasion), 
vasculature (presence, Doppler and CEUS characteristics). The substrate on which the tumor 
condition develops (if the liver is normal or if there is evidence of diffuse liver disease) and 
the developing context (oncology, septic) are also added. Particular attention should be paid 
to the analysis of the circulatory bed. Microcirculation investigation allows for 
discrimination between benign and malignant tumors. Characteristic elements of malignant 
circulation are vascular density, presence of vessels with irregular paths and size, some of 
them intercommunicating, some others blocked in the end with “glove finger” appearance, 
the presence of arterio-arterial and arterio-venous shunts, lack or incompetence of arterial 
precapillary sphincter made up of smooth musculatures (Weidener et al, 1991). 
Diagnosis and characterization of liver tumors require a distinct approach for each group of 
conditions, using the available procedures discussed above for each of them. The correlation 
with the medical history, the patient’s clinical and functional (biochemical and 
hematological) status are important elements that should also be considered. 
2.2 Benign liver tumors 
They generally develop on normal or fatty liver, are single or multiple (generally 
paucilocular), have distinct delineation, with increased echogenity (hemangiomas, benign 
focal nodular hyperplasia) or absent, with posterior acoustic enhancement effect (cysts), 
have distinct delineation (hydatid cyst), lack of vascularization or show a characteristic 
circulatory pattern,  displace normal liver structures and even neighboring organs (in case of 
large sizes), are quite elastic and do not invade liver vessels. The patient has a good general 
status, as tumors are often asymptomatic, being incidentally discovered. 
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2.2.1 Liver cysts 
They can be single or multiple, with variable size, generally less than 20 mm (congenital). 
Rarely, sizes can reach several centimeters, leading up to the substitution of a whole liver 
lobe (acquired, parasitic). They may be associated with renal cysts; in this case the disease 
has a hereditary, autosomal dominant transmission (von Hippel Lindau disease).  
The ultrasound appearance is a well defined lesion, with very thin, almost unapparent 
walls, without circulatory signal at Doppler or CEUS investigation. The content is 
transonic suggesting fluid composition. The presence of membranes, abundant sediment 
or cysts inside is suggestive for parasitic, hydatid nature. Posterior from the lesion the 
"acoustic enhancement" phenomenon is seen, which strengthens the suspicion of fluid 
mass. They typically displace normal liver vessels but no vascular or biliary invasion 
occurs. 
      
Fig. 2. Liver cyst – left image. Hydatid liver cyst (2D exam) – right image. Diagnostic criteria 
are the presence of membranes and sediment inside. 
2.2.2 Hemangioma 
It is the most common liver tumor with a prevalence of 0.4 - 7.4%. It is generally 
asymptomatic but also can be associated with pain complaints or cytopenia and/or 
anemia when it is very bulky. It is unique or paucilocular. It can be associated with other 
types of benign liver tumors. Characteristic 2D ultrasound appearance is that of a very 
well defined lesion, with sizes of 2-3 cm or less, showing increased echogenity and, when 
located in contact with the diaphragm, a "mirror image" phenomenon can be seen. When 
palpating the liver with the transducer the hemangioma is compressible sending 
reverberations backwards. Doppler exploration reveals no circulatory signal due to very 
slow flow speed. CEUS investigation has real diagnosis value due to the typical behavior 
of progressive CA enhancement of the tumor from the periphery towards the center. The 
enhancement is slow, during several minutes, depending on the size of hemangioma and 
on the presence (or absence) of internal thrombosis. During late (sinusoidal) phase, if 
totally "filled" with CA, hemangioma appears isoechoic to the liver. Deviations from the 
above described behavior can occur in arterialized hemangiomas or those containing 
arterio-venous shunts. In these cases differentiation from a malignant tumor is difficult 
and requires other imaging procedures, follow up and measurements of the tumor at 
short time intervals. 
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Fig. 3. Hepatic hemangioma (2D). The lesion is located in the left hepatic lobe. Note precise 
delineation, their increased echogenity and the heterogeneous internal structure. 
 
Fig. 4. Hepatic hemangioma (CEUS). Progression of CA from the periphery toward the 
center of the lesion is evidenced by examination at various time intervals (a – arterial phase; 
b – late phase). 
2.2.3 Focal nodular hyperplasia 
It is a tumor developed secondary to a circulatory abnormality with abundant arterial 
vessels having a characteristic location in the center of the tumor, within a fibrotic scar. A 
radial vessels network develops from this level with peripheral orientation. The tumor’s 
circulatory bed is rich in microcirculatory and portal venous elements. The incidence is 
higher in younger women and tumor development is accelerated by oral contraceptives 
intake. 2D ultrasound appearance is a fairly well-defined mass, with variable sizes, usually 
single, solid consistency with inhomogeneous structure. Rarely the central scar can be 
distinguished. Spectral Doppler examination detects central arterial vessels and CFM 
exploration reveals their radial position. CEUS examination shows central tumor filling of 
the circulatory bed during arterial phase and completely enhancement during portal venous 
phase. During this phase the center of the lesion becomes hypoechoic, enhancing the tumor 
scar. During the late phase the tumor remains isoechoic to the liver, which strengthens the 
diagnosis of benign lesion.  
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Fig. 5. Benign focal nodular hyperplasia (CEUS). Gray scale examination (left) detects the 
lesion. CEUS examination (right) allows characterization of tumor nature based on central 
contrast enhancement and centrifugal dispersion. 
2.2.4 Adenoma 
It is a benign tumor made up of normal or atypical hepatocytes. It has an incidence of 0.03%. 
Its development is induced by intake of anabolic hormones and oral contraceptives. The 
tumor is asymptomatic, but may be associated with right upper quadrant pain in case of 
internal bleeding. 2D ultrasound shows a well-defined, un-encapsulated, solid mass. It may 
have a heterogeneous structure in case of intratumoral hemorrhage. Doppler examination 
shows no circulatory signal. CEUS exploration is quite ambiguous and cannot always 
establish a differential diagnosis with hepatocellular carcinoma. Thus, during the arterial 
phase there is a centripetal and inhomogeneous enhancement. During the portal venous 
phase there is a moderate wash out. During late phase the appearance is isoechoic or 
hypoechoic, due to lack of Kupffer cells. 
2.3 Malignant liver tumors 
Malignant liver tumors develop on cirrhotic liver (hepatocellular carcinoma, HCC) or 
normal liver (metastases). They are single or multiple (especially metastases), have a 
variable, generally imprecise delineation, may have a very pronounced circulatory signal 
(hepatocellular carcinoma and some types of metastases), have a heterogeneous structure 
(the result of intratumoral circulatory disorders, consequence of hemorrhage or necrosis) 
and are firm to touch, even rigid. The patient's general status correlates with the underlying 
disease (vascular and parenchymal decompensation for liver cirrhosis, weight loss, lack of 
appetite and anemia with cancer). 
2.3.1 Hepatocellular carcinoma (HCC) 
It is the most common liver malignancy (Parkin et al, 2005). It develops secondary to 
cirrhosis (in approx. 80% of cases) (Llovet et al, 2003) therefore, ultrasound examination 
every 6 months combined with alpha fetoprotein (AFP) determination is an effective 
method for early detection and treatment monitoring for this type of tumor (Bruix & 
Sherman 2005; Llovet & Bruix 2008). Clinically, HCC overlaps with advanced liver cirrhosis 
(long evolution, repeated vascular and parenchymal decompensation, sometimes bleeding 
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due to variceal leakage) in addition to accelerated weight loss in the recent past and lack of 
appetite. 
HCC appearance on 2D ultrasound is that of a solid tumor, with imprecise delineation, 
with heterogeneous structure, uni- or multilocular (encephaloid form).  An "infiltrative" 
type is also described which is difficult to discriminate from liver nodular reconstruction 
in cirrhosis. Typically HCC invades liver vessels, primarily the portal veins but also the 
hepatic veins (Badea R. & Badea Gh, 1991). Doppler examination detects a high speed 
arterial flow and low impedance index (correlated with described changes in tumor 
angiogenesis). The spatial distribution of the vessels is irregular, disordered. CEUS 
examination shows hyperenhancement of the lesion during the arterial phase. During the 
portal venous phase there is a specific "wash out" of ultrasound contrast agent (UCA) and 
the tumor appears hypoechoic during the late phase. Poorly differentiated tumors may 
have a stronger wash out leading to an isoechoic appearance to the liver parenchyma 
during portal venous phase. This appearance was found in approx. 30% of cases (Nicolau 
et al, 2004). The described changes have diagnostic value in liver nodules larger than  
2 cm.  
 
    
 
Fig. 6. Encephaloid hepatocellular carcinoma (CEUS). Contrast tumor enhancement is 
observed on the left during arterial phase. The “wash-out” phenomenon can be seen on the 
right, during portal venous phase. 
Ultrasound is useful in HCC detection, stadialization and assessing therapeutic efficacy. 
In terms of staging related to therapy effectiveness, the Barcelona classification is used 
(Llovet et al, 1999) which identifies five HCC stages. Curative therapy is indicated in early 
stages, which include very early stage (single nodule <2 cm), curable by surgical resection 
(survival 50-70% five years after surgical resection) (Llovet et al, 2003) and early stage 
(single nodule of 2-5 cm, or up to 3 nodules <3 cm) which can be treated by 
radiofrequency ablation (RFA) and liver transplantation. Intermediate stage (polinodular, 
without portal invasion) and advanced stage (N1, M1, with portal invasion) undergo 
palliative therapies (TACE and sorafenib systemic therapy) and in the end stage only 
symptomatic therapy applies. 
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2.3.2 Cholangiocarcinoma 
It develops on non cirrhotic liver. 2D ultrasound appearance is uncharacteristic - solid mass 
with heterogeneous structure, poorly delineated, often with peripheral location and weak 
Doppler circulation signal. CEUS examination reveals a moderate enhancement of the 
tumor periphery during arterial phase followed by wash-out during portal venous phase 
and hypoechoic appearance during late phase. 
2.3.3 Liver metastases 
US examination is required to detect liver metastases in patients with oncologic history. In 
addition, the method can incidentally detect metastases in asymptomatic patients. Early 
identification (small sizes, small number) is important to establish an optimal course of 
treatment which can be complex (chemotherapy, radiofrequency ablation, surgical 
resection) but welcomed. In addition, discrimination of synchronous lesions that have a 
different nature is also important knowing that up to 25-50% of liver lesions less than 2 cm 
detected in cancer patients may be benign (Kreft et al, 2001). US sensitivity for metastases 
detection varies depending on the examiner’s experience and the equipment used and 
ranges between 40-80% (Wernecke et al, 1991). Sensitivity is conditioned by the size and 
acoustic impedance of the nodules. For a lesion diameter below 10 mm US accuracy is 
greatly reduced, reaching approx. 20%. Other elements contributing to lower US 
performance are: excessive obesity, fatty liver disease, hypomobility of the diaphragm, and 
certain patterns of hyperechoic or isoechoic metastases that can be overlooked or can mimic 
benign conditions. Conventional US appearance of metastases is uncharacteristic, consisting 
of circumscribed lesions, with clear, imprecise or "halo" delineation, with homogeneous or 
heterogeneous echo pattern. They can be single (often liver metastases from colonic 
neoplasm) or multiple. Echogenity is variable. When increased, they can compress the bile 
ducts (which may be dilated) and the liver vessels. Liver involvement can be segmental, 
lobar or generalized. In this situation a pronounced hepatomegaly occurs. Generally, 
metastases have non-characteristic Doppler vascular pattern, with few exceptions (carcinoid 
metastases). Cyst-adenocarcinoma metastases due to semifluid content may have a 
transonic appearance. When increasing, they can result in central necrosis. CEUS 
examination is a real breakthrough for detection and characterization of liver metastases. 
Increased performance is based on identifying specific vascular patterns during the arterial 
phase and seeing metastases in contrast to normal liver parenchyma during the sinusoidal 
phase. CEUS increased accuracy is due to the different behavior of normal liver parenchyma 
(captures CA in Kuppfer cells) against tumor parenchyma (does not contain Kuppfer cells, 
therefore CEUS appearance is hypoechoic). To this adds the particularities of intratumoral 
circulation represented by a reduced arterial bed compared to that of the surrounding 
normal liver and the absence of the portal vessels (Cosgrove & Blomley 2004). In terms of 
vascularity, metastases can be hypovascular (in gastric, colonic, pancreatic or ovarian 
adenocarcinomas) with hypoechoic pattern during arterial phase, and similar during portal 
venous and late phases, respectively hypervascular (neuroendocrine tumors, malignant 
melanoma, sarcomas, renal, breast or thyroid tumors) with hyperechoic appearance during 
arterial phase, with washout during the portal venous phase and hypoechoic pattern  
30 seconds after injection (Larsen, 2010). 
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Fig. 7. Liver metastases (CEUS). Peripheral vascular pattern of the lesion is observed on the 
left in colon cancer metastasis. Lesion hyperenhancement in ovarian cancer liver metastasis 
is seen on the right during the arterial phase. 
Using CEUS examination to detect metastases a sensitivity of 80-95% is obtained, similar to 
that of contrast CT and MRI (Quaia et al, 2006 ; Piscaglia et al, 2007). Intraoperative use of 
the procedure increases its performance even if it does not have a decisive contribution to 
change the therapeutic behavior (Konopke et al, 2005). Limitations of the method are those 
related to US penetration (pronounced fatty liver disease, deep lesion, excessive obesity) and 
to the experience of the examiner. To this the risk of confusion between hypervascular 
metastases, hepatocellular carcinoma and hemangioma and the confusion between 
hypovascular metastases and small liver cysts is added. Routine use of CEUS examination to 
detect liver metastases is recommended when conventional US examination is not 
conclusive, when precise information on some injuries (number, location) is necessary in 
conjunction with contrast CT/MRI and to assess the effectiveness of treatment when using a 
antiangiogenic therapy for hypervascular metastases (Claudon et al, 2008). The method 
cannot replace CT/MRI examinations which have well established indications in oncology 
(Larsen, 2010). 
2.4 Pseudotumors and inflammatory masses of the liver 
Besides the entities listed above inflammatory masses or even pseudo-masses can occur. 
Their diagnosis is quite difficult and the criteria used for differentiation are often 
insufficient, requiring morphologic diagnostic procedures, use of other diagnostic imaging 
methods or patient reevaluation from time to time. This includes lesions developed on liver 
parenchyma reconstruction, as occurs in cirrhosis, steatosis accumulation or in case of acute 
or chronic inflammatory diseases. 
2.4.1 Focal steatosis 
It consists of localized accumulation of fat-rich liver cells. In some cases this accumulation can 
mimic a liver tumor. Sometimes the opposite phenomenon can be seen, that is an "island" of 
normal parenchyma in a “shining” liver.  In both cases ultrasound examination identifies a 
well defined, un-encapsulated area, with echostructure and vasculature similar to those of 
normal liver parenchyma. The lesion can have different forms, most cases being oval and 
located in the IVth segment, anterior from the hepatic hilum. It occurs in dyslipidemic or 
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alcohol intake patients with normal physical and biological status. Benign diagnosis 
confirmation is made using CEUS examination which proves a normal circulatory bed similar 
to adjacent liver parenchyma in all three phases of investigation (Molins et al, 2010). 
2.4.2 Liver abscess 
Liver abscess have heteromorphic ultrasound appearance, the most typical being that of a 
mass with irregular shapes, fringed, with fluid or semifluid content, with or without air inside. 
Doppler examination shows the lack of vessels within the lesion. CEUS exploration shows 
hyperenhancement during arterial phase close to the lesion, this being suggestive of a liver 
parenchymal hyperemia. During venous and sinusoidal phase the pattern is hypoechoic, and 
the central fluid is contrast enhanced. CEUS examination is useful because it confirms the 
clinical suspicion of abscess. In addition, it allows for an accurate measurement of the 
collection size and an indication regarding its topography inside the liver (lobe, segment). 
 
Fig. 8. Liver abscess (2D and CEUS). 2D Examination reveals the fluid nature of the mass 
and imprecise delineation. CEUS examination shows congestion in the surrounding liver 
parenchyma and excludes a vascular tumor. 
3. Preneoplastic status. Cirrhotic liver monitoring 
Cirrhotic liver is characterized by the occurrence of nodules with different sizes and 
evolution degrees, so that regenerative nodules, dysplastic nodules and even early 
hepatocellular carcinoma can coexist at some moment during disease progression. There are 
studies showing that between 59-94% of newly diagnosed liver nodules in cirrhotic patients 
have malignant histology and up to 50% of hyperechoic lesions, with ultrasound appearance 
of hemangioma, ultimately prove to be hepatocellular carcinoma. Therefore, current practice 
in many centers considers that any new lesion revealed in a cirrhotic patient should be 
regarded as malignant until otherwise proven (Andreana et al, 2009). There are three 
categories of cirrhotic liver nodules: regenerative, dysplastic (considered as premalignant 
conditions) and tumoral (HCC) (Int WP, 1995). 
3.1 Regenerative nodules (RN) 
These lesions are well defined, with isoechoic or hypoechoic appearance and sizes less than 
1 cm. They are high in numbers and have a more or less uniform distribution, involving all 
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liver segments. They can crowd resulting in large pseudo tumors. At Doppler examination, 
these nodules have no circulatory signal. CEUS exploration is indicated when a nodule is 
different against the general pattern of restructured liver either by different echogenity or by 
a different size than the majority of nodules. During the arterial phase, the signal is weak or 
absent. During the portal venous and late phase, the appearance is persistently isoechoic. 
Generally, RN is not distinct from the surrounding parenchyma. CEUS examination is 
useful to exclude an active lesion at the moment of exploration but does not have absolute 
prognostic value; therefore the patient should be periodically examined at short intervals 
(Kojiro, 2004; Bolondi et al, 2005). Correlation with clinical status and AFP measurements is 
required. 
 
Fig. 9. Regenerative nodule (CEUS). One can see the hypovascular pattern of the solid 
nodule, with a size <10 mm. 
3.2 Dysplastic nodules (DN) 
These lesions have various patterns (hypo or hyperechoic) with at least 1 cm diameter. They 
are hepatocytes with dysplastic changes, but without clear histological criteria for 
malignancy. They are divided into low-grade dysplastic nodules, where cellular atypia are 
mild and high-grade dysplastic nodules with moderate or severe cellular atypia, but 
without any established signs of malignancy. Occasionally, well-differentiated HCC foci can 
be identified in high-grade dysplastic nodules (appearance called "nodule in nodule") 
(Minami & Kudo, 2010). Most authors accept the carcinogenesis process as a progressive 
transformation of DN from low-grade to high-grade and into HCC. The nodule’s 
vasculature changes progressively, correlated with the degree of malignancy, and it is 
characterized by decrease until absence of portal venous input and by increase of arterial 
intratumoral input. Neoformation vessels occur with increasing degree of dysplasia. Arterial 
neovascularization is enhanced in a chaotic and explosive way, while normal, arterial and 
portal vasculature continues to decline. High-grade dysplastic nodules are hypo-
vascularized both arterial and portal phases, while early HCC nodules may have similar 
arterial pattern with the surrounding parenchyma or exacerbated, and portal hypo-
vascularization. In moderate or poorly differentiated HCC (classic HCC) tumor nutrition is 
performed only by neoformation vessels (abundant), the normal arterial and portal 
vasculature completely disappearing (Matsui 2004). This behavior of intratumoral 
vascularization is typical for HCC and is the key to imaging diagnosis (Lencioni et al 2008).  
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B-mode ultrasonography is unable to distinguish between regenerative nodules and 
"borderline" lesions such as dysplastic nodules and even early HCC. Doppler examination 
also has a low sensitivity in differentiating dysplastic nodules from early HCC. Doppler 
signal may be absent in both regenerative and dysplastic nodules. Some authors indicate the 
presence of venous type Doppler flow which reflects the portal venous nutrition of the 
nodule as a characteristic feature of dysplastic nodules and early HCC (Minami & Kudo, 
2010). Other authors noticed the presence of an arterial flow with small frequency variations 
and a normal resistivity index (RI) (Lencioni et al 2008). 
On CEUS examination both RN and DN may have quite a variable enhancement pattern. 
Generally, both nodules enhances identically with the surrounding liver parenchyma after 
UCAs injection.  Dysplastic nodules are hypovascular in the arterial phase. In case of high-
grade dysplastic nodule sometimes a hypervascularization can be detected, but without 
associating "wash out" during portal and late CEUS phases. In these cases, biopsy may 
clarify the diagnosis. 
 
Fig. 10. Dysplastic nodule (2D, CFM, CEUS). The nodule is well-defined with a size between 
10- 20 mm, lacks vessels in CFM and CEUS exploration. 
3.3 Early hepatocellular carcinoma (Early HCC) 
The suggestive appearance of early HCC on 2D ultrasound examination is that of hypo-
echoic nodule, with distinct pattern, developed on cirrhotic liver. Hypoechoic appearance is 
characteristic of moderate/poorly differentiated HCC, with low or absent fatty changes. 
Rarely, HCC may appear isoechoic, consist of a tumor type with a higher degree of 
differentiation and therefore with slower development. Another common aspect is "bright 
loop" or "nodule-in-nodule" appearance, hypoechoic nodules in a hyperechoic tumor. 
(Minami & Kudo, 2010). 
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Spectral Doppler characteristics of early HCC overlap those of the dysplastic nodule, as they 
are represented by the presence of portal venous signal type or arterial type with normal RI 
(well differentiated HCC) or increased RI (moderately or poorly differentiated HCC). The 
CFM exploration identifies a chaotic vessels pattern. 
On CEUS examination, early HCC has an iso- or hypervascular appearance during the 
arterial phase followed by wash out during portal venous and late phase. There are studies 
showing that the wash out process is directly correlated with the size and features of 
neoplastic circulatory bed. Thus, highly differentiated HCC illustrates the phenomenon of 
late or even very late "wash out" while poorly differentiated HCC has an accelerated wash 
out at the end of arterial phase (Strobel et al, 2005; von Herbay et al, 2009; Jang et al, 2009). It 
is therefore mandatory to analyze all these three phases of CEUS examination for a proper 
characterization of liver nodules. Tumor wash out at the end of the arterial phase allows the 
HCC diagnosis with a predictability of 89.5%. Some authors consider that early pronounced 
contrast enhancement of a nodule within 1-2 cm developed on a cirrhotic liver is sufficient 
for HCC diagnosis (Jang et al, 2009). These results prove that for a correct characterization of 
the lesions it is necessary to extend the examination time to 5 minutes or even longer (von 
Herbay et al, 2009). 
 
Fig. 11. Early hepatocellular carcinoma (2D, CFM). The 2D examination reveals a solid, 
hypoechoic nodule in IVth liver segment, without encapsulation. CFM shows a central vessel 
with ramifications to the periphery. The underlying liver is cirrhotic. 
 
Fig. 12. Early hepatocellular carcinoma (2D, CFM). “Nodule in nodule” image: small 
hypoechoic early HCC inside monitored dysplastic nodule. 
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3.4 The ultrasound value in HCC "screening" 
Baseline 2D ultrasound has an important role in surveillance programs for patients at risk to 
develop HCC (Bruix & Sherman, 2011). The examination has an acceptable sensitivity which 
increases with the tumor size. Sensitivity varies between 42% for lesions <1 cm and 95% for 
tumors larger than 1 cm, and specificity can reach 90% (Andreana et al, 2009). Optimal time 
interval for ultrasound screening of “at risk” population is 6 months as it results from 
clinical trials that investigated the tumor size doubling time (Bruix, 2005; Maruyama et al, 
2008). For a recently developed nodule the dimensional criteria will be taken into account. 
Thus, for a nodule with a size of less than 10 mm the patient will be reevaluated by 
ultrasound every 3 months, as the growth trend is an indication for completion of 
investigations with other diagnostic procedures; at a size between 10 - 20 mm two 
concordant imaging procedures are necessary, supplemented if necessary by an ultrasound 
guided biopsy; at a size over 20 mm one single dynamic imaging technique with 
characteristic appearance is enough for positive diagnostic. In uncertain cases 
complementary dynamic imaging techniques or biopsy should be performed. When 
Doppler exploration is not enough, CEUS examination will be performed (Gaiani et al, 
2001). One should always keep in mind the risk of false positive results for HCC in case of 
cholangiocarcinomas so complementary diagnostic procedures should be considered (Bruix 
& Sherman, 2011). 
The effectiveness of screening programs is proved by an increase in detection rate of HCC 
<2 cm (from <5% in the 90s in Europe to > 30% today in Japan) with curative therapy 
options (Llovet & Bruix 2008). The main problem of ultrasound screening is that, in order to 
be cost-effective, it should be applied to the general population and not in tertiary hospitals. 
This raises the importance of the operator and equipment dependent part of the ultrasound 
examination (Bruix et al, 2001). The efficiency of such a program is linked to the functional 
liver parenchyma of the cirrhotic patient. Therefore, some authors argue that screening 
should be excluded in patients with etiologies that prevent curative treatment or in patients 
with advanced liver disease (Child-Pugh class C) (Zapata et al, 2010). 
After curative therapies (surgical resection, local ablative therapies) continuing ultrasound 
screening is recommended first at 1 month then at 3 months intervals after the therapy to 
assess the effectiveness of therapy and to detect other nodules. 
4. Antitumor therapies 
Ultrasound exploration can be an effective procedure for the assessment of liver tumors 
response to treatment. Over the years, different criteria for assessing the effectiveness of 
curative or palliative therapies have been considered. Now it has been proved that the 
degree of tumor necrosis is not correlated with tumor diameter, therefore simple 
measurement of the tumor diameter (RECIST criteria) is not enough for therapy assessment. 
Currently, local response to treatment is focused on tumor necrosis diagnosed by contrast 
dynamic imaging techniques and recognized by the presence of intratumoral non-enhanced 
areas. Local response to treatment is defined as:  
a. complete response, defined as complete disappearance of all known lesions (absence of 
tumor enhanced areas, reflecting total tumor necrosis) and absence of other new lesions 
determined by two observations not less than 4 weeks apart; 
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b. partial response, defined as more than 50% reduction in total tumor enhancement in all 
measurable lesions, determined by two observations not less than 4 weeks apart 
c. stable disease (is not described by a, b, or d)  
d. progressive disease, defined as 25% increase in size of one or more measurable lesions 
or the appearance of new lesions (Bruix et al, 2001). 
4.1 Techniques for evaluating the efficiency of therapy  
The efficiency of 2D ultrasound is low in assessing the effects of HCC or metastasis therapy, 
as it is unable to differentiate viable tumor tissue from post-therapy tumor necrosis. 
However, it is able to detect the appearance of new lesions and to assess the occurrence of 
any complications of disease progression (ascites or portal vein thrombosis). Color Doppler 
ultrasound can be useful sometimes being able to show the presence of intratumoral 
vasculature as a sign of incomplete therapy or intratumoral recurrence. The absence of 
Doppler signal does not exclude the presence of viable tumor tissue. CEUS exploration, by 
its ability to enhance intra-lesion microcirculation, has proved its utility in monitoring 
therapeutic efficacy. Its indications are defined for HCC ablative treatments (pre, intra and 
post-therapy), while monitoring of systemic therapies of HCC and metastases are not 
validated indications at this time, but with proved efficacy in extensive clinical trials 
(Claudon et al, 2008). CEUS examination cannot completely replace the other imaging 
diagnostic methods currently in use because of the known limitations of the ultrasound 
method (operator/ equipment dependent, ultrasound examination limitations). In addition 
to bloating, in cancer patients post-therapy steatosis occurs, which prevent deep visibility. 
Spiral CT scan remains the method of choice in monitoring cancer therapies because it 
provides an overview of tumor extension and it is not limited by bloating or steatosis 
(Bartolozzi et al, 1999). 
Gadolinium MRI examination is a procedure used more and more often, and its advantages 
are the absence of irradiation and its high sensitivity in tumor vasculature detection, 
especially in smaller tumors (Dromain et al, 2002). However it remains an expensive and not 
a very accessible procedure, although it has a high specificity. Currently, CEUS and MRI are 
considered complementary methods to CT scan. 
4.2 Ultrasound monitoring ablative therapies (alcoholization - PEI, radiofrequency 
ablation - RFA) 
Ablative therapies are considered curative treatments for HCC together with surgical 
resection and liver transplantation and they are indicated for early tumor stages in patients 
with good liver function (Bruix & Sherman, 2005; Bruix & Sherman, 2011). Also they are 
successfully applied in the treatment of liver metastases, where surgical resection is 
contraindicated. They are chemical (intratumoral ethanol injection) or thermal 
(radiofrequency, laser or microwave ablation). They are applied in order to obtain a full 
therapeutic response, without affecting liver function. Complete response is locally proved 
by complete tumor necrosis with a safety margin around the tumor. 
2D ultrasound, Doppler ultrasound and especially CEUS can play an important role in pre-
therapeutic staging, particularly when sectional imaging investigations (CT, MRI) provide 
uncertain results or are contraindicated. During the interventional procedure, ultrasound 
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allows guidance of the needle into the tumor. CEUS allows guidance in areas of viable tissue 
and avoids intratumoral necrotic areas. CEUS also allows assessment of therapeutic effect 
immediately post-procedure (with the possibility of reintervention in case of partial response) 
(Claudon et al, 2008). To accurately assess the effectiveness of treatment it is mandatory to 
compare the tumor diameter before therapy with the ablation area. The volume of damaged 
tissue must be higher than the initial tumor volume. CEUS appearance is that of central non-
enhanced area showing a peripheral homogeneous hyperenhanced rim due to post-procedure 
inflammation. 24 hours after the procedure the inflammatory peripheral rim is thinning and 
the necrotic area appears larger than at the previous examination. Thus, a possible residual 
tumor may appear more evident. Residual tumor has poorly defined edges, irregular shape, 
and the tumor diameter is unchanged. Residual tumor tissue is evidenced at the periphery of 
the tumor as an eccentric area behaving as the original tumor at CEUS examination, with 
arterial hyperenhancement and portal and late wash-out. Ultrasound examination 24 hours 
after the procedure, including CEUS, can show apart from the character of the lesion any 
potential post-intervention complications (e.g. active bleeding). 
In the first days after RFA both CEUS and spiral CT have low sensitivity in assessing 
therapeutic efficacy. CT sensitivity 24 hours post-therapy is reported to be even lower than 
CEUS (Vilana et al, 2006). Difficulties in CEUS examination result from post-lesion 
hyperemia, presence of intratumoral air, ultrasound limitations (too deep lesion or the 
presence of fatty liver) or lack of patient’s cooperation (immediately after therapy). For this 
reasons contrast imaging (CT or CEUS) control should be performed one month after 
ablation to confirm the result of the therapy (Spârchez et al, 2009). 
Local recurrence is defined as recurrence of a hyperenhanced area at tumor periphery in the 
arterial phase, with portal and late wash-out. Sometimes, especially for HCC treated by 
alcoholization (PEI) hyperenhanced septa or vessels can be shown inside the lesion 
(Spârchez et al, 2009). 
In case of successful treatment, US monitoring using CEUS is performed every three 
months. Although CE-CT and/or MRI are considered the method of choice in post-therapy 
monitoring, CEUS can be used in follow-up protocols (Claudon et al, 2008), its diagnostic 
accuracy being equivalent to that of CE-CT or MRI (Frieser et al, 2011). 
    
Fig. 13. Assessment of therapeutic efficacy on ultrasound (2D, CFM, CEUS). US exam shows 
vascular Doppler signal at CFM (left)  and CEUS examination reveals incomplete therapy 
(right). 
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4.3 Ultrasound monitoring of TACE therapy (transarterial chemoembolization)  
Transarterial chemoembolization (TACE) is part of palliative therapies for HCC used in 
intermediate stages of the disease. It consists of selective angiographic catheterization of the 
hepatic artery and injection of chemotherapeutic agents (usually adriamycin, but other 
molecules are currently the subject of clinical trials), followed by embolization of hepatic 
artery with gelfoam, alcohol or metal rings (Bruix & Sherman, 2005). A similar procedure is 
transarterial embolization but without chemotherapeutic agents injection, used in the 
treatment of hypervascular liver metastases. These therapies are based on the 
predominantly arterial vasculature of HCC and hypervascular metastases, while the 
remaining liver parenchyma has a dual vascular intake, predominantly portal. Their efficacy 
is high only for lesions who are hyperenhanced during arterial phase. The role of US is 
limited in the first few days after the procedure, and refers only to its complications, due to 
Lipiodol retention mainly intratumoral, but also diffusely intrahepatic. On ultrasound, 
Lipiodol appears intensely hyperechoic inside the tumor, with significant posterior 
attenuation which make US examination more difficult. On the other hand, CE-CT is also 
limited by the presence of Lipiodol (iodine oil), therefore the evaluation of therapeutic 
efficiency is currently made by indirect assessing Lipiodol binding to the tumor using non-
enhanced CT (Maruyama et al, 2008). CE-MRI is not influenced by the presence of Lipiodol, 
but it is an expensive method and still difficult to reach. Several studies have proved similar 
efficacy, even superior, of CEUS compared to CE-CT and CE-MRI for the evaluation of post-
TACE treatment results, while other studies have shown the limitations of CEUS especially 
for deep or small lesions. Given the CEUS limitations, currently some authors consider CT 
as standard method for the evaluation of TACE and local ablative therapies and CEUS and 
CE-MRI as complementary methods (Lim et al, 2006, Maruyama et al, 2008). Monitoring 
TACE therapeutic results by contrast imaging techniques is performed as for ablative 
therapies initially after one month then after every 3 months post-TACE. 
Given that TACE is indicated only for hyperenhanced lesions during arterial phase, CEUS 
plays a very important role in monitoring the dysplastic nodules to identify the moment 
when changes occur in arterial vasculature, being able to have an early therapeutic 
intervention in order to limit tumor progression, to increase patient survival, and thus to 
create a bridge to liver transplantation. 
  
Fig. 14. Small HCC is seen on the left (nodule in nodule). Efficient chemoembolization of the 
nodule (right). CEUS examination shows no circulatory signal within the nodule.  
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4.4 Ultrasound monitoring of systemic therapies 
Systemic therapies are procedures based on the affinity of certain molecules to inhibit either 
tumor cell replication or multiplication of neoplastic vasculature (antiangiogenic therapies). 
They are intravenously administered and are indicated in advanced stages of liver tumor 
diseases, when there are no other effective therapeutic solutions. Among ultrasound 
techniques, CEUS is the one that brought a significant benefit not only by increasing the 
sensitivity and specificity of ultrasound in detecting liver metastases, but also by assessing 
the efficacy of systemic therapy for HCC and metastases. The method has been adopted by 
oncologists since 2003, because it involves no irradiation and has no hepatic or renal toxicity, 
and it is now currently used in tumor therapeutic evaluation (Lassau et al, 2011). It is 
currently used in large clinical trials aimed at determining the efficacy of different types of 
anti-angiogenic molecules by quantifying intratumoral perfusion based on the statistical 
analysis performed using specific software during post-processing in order to assess 
therapeutic efficacy as early as possible. 
4.5 Ultrasound monitoring of post-surgical resection status 
Surgical resection is the treatment of choice for non-cirrhotic or cirrhotic patients with 
well preserved liver function with single liver lesion. After resection, recurrence rate 
exceeds 70% at 5 years and is mainly due to primary tumor dissemination. The strongest 
predictors of tumor recurrence are the development of other tumors near the primary 
tumor scar and vascular microinvasion (Bruix & Sherman, 2005). 2D ultrasound is used 
within screening programs. CEUS efficacy has not been proven so far in monitoring post-
resection patients. 
5. Other applications of ultrasound in liver tumor pathology. Technical 
progress 
Ultrasound has known a great development arising from the need to increase patient access 
to advanced investigations while avoiding procedures using radiation (CT), contrast agents 
with allergic potential (iodine substances) and hepatic or renal toxic agents. 
Interventional and intraoperative ultrasound. Ultrasound exploration by maneuverability of the 
equipment and dynamic character of the image allows guided interventional procedures or 
intraoperative examination. Combining ultrasound with such procedures is necessary due 
to the lack of specificity of the method in case of tumors. Even if tumor markers for defining 
the nature of some masses are available, their accuracy is not good enough; therefore 
biological samples from the nodules detected by imaging is often required. Accuracy of 
ultrasound guided puncture in the diagnosis of liver tumors is dependent on the operator’s 
experience and can reach up to 87.5 - 99% (Horigome et al, 1999). The extracted material can 
be either a histology fragment or cytology aspiration; in both cases the credibility of the 
method is sufficient to ensure optimal cancer therapies (Badea R & Badea Gh 1991). 
Intraoperative ultrasound is also a complementary investigation that allows detection of 
very small nodules. In addition it allows the characterization of tumor using Doppler and 
CEUS procedure as well as guided interventional procedures such as intraoperative PEI or 
RFA. 
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Targeted therapy using contrast agents. The introduction of second generation contrast agents 
has been a great progress. Diagnostic performance is already proven. A step forward is 
tumor targeted therapy under ultrasound guidance. The principle is that of transporting 
chemotherapeutic agents to the target using microbubbles as vectors. Experiments have 
been made for binding different substances and/or genes to the lesion, with local release by 
"breaking" and intracellular penetration using the phenomenon of cellular membrane 
permeability called "sonoporation" (Lindner, 2004, Newman & Bettinger, 2007). 
Image fusion. Techniques for image fusion obtained by different imaging procedures allow 
the correlation of real-time ultrasound examination with CT or MRI images, enabling 
positioning of the needle in relation to the exact position of the tumor. The technique allows 
a better guidance both for biopsies and percutaneous ablative procedures, replacing CT 
guidance and thus avoiding irradiation. Combination with CEUS allows a better 
characterization of lesions as well as successful monitoring of percutaneous procedures or 
TACE effects (Sandulescu et al, 2011; Ewertsen et al, 2011). 
Elastography. It was initially introduced in practice to assess the degree of fibrosis in chronic 
liver disease. In liver tumors it allows detection of liver nodules due to the difference of 
elasticity between the hepatic nodule and the parenchyma. There are few studies that try to 
assess the benign or malignant character of the lesion based only on elasticity. By 
combination with CEUS the method could be beneficial for early detection and 
characterization of HCC. 
High Intensity Focused Ultrasound (HIFU). It is a new technique capable of destroying tumor 
tissue by hyperthermia, allowing percutaneous ablation without requiring tumor puncture. 
There are studies showing the efficacy of this technique in combination with TACE, with 
anti-tumor effect and better survival than using TACE alone (Wu, 2005). The method is 
expected to be an alternative to PEI and RFA because it avoids the puncture of the cirrhotic 
liver, but more studies are needed to prove its efficacy as a single therapy in the curative 
treatment of HCC (Maruyama et al, 2008). 
Techniques for visualizing blood circulation independently from the angle of insonation 
based on transversal oscillation of red blood cells groups. This technique is now 
implemented on conventional transducers and can real time evidence different features of 
the blood flow visualized so far only on MRI angiography (Hansen et al, 2011). 
6. Conclusions 
Ultrasound exploration using current technologies has excellent possibilities for practical 
use. Several elements related to the lack of standardization and reproducibility of 
ultrasound procedures as well as operator-dependent nature of the method require 
structured approach to its use in liver tumors pathology (Bolondi et al, 2007). Structuring 
these applications and description of their actual performance are included in successive 
recommendations made by expert groups, known as "EFSUMB guidelines" (Albrecht et al, 
2004; Claudon et al, 2008). In the current stage the following applications in liver pathology, 
especially in tumors are accepted as valid and represent indications for CEUS: 
a. characterization of nodular lesions found on non-cirrhotic liver. Ultrasound examination is 
often the first imaging procedure performed in patients with abdominal pathology. 
Quite often lesions are detected and their nature has to be further on defined. 
Ultrasound procedures that allow achieving this purpose are multiple and 
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complementary: 2D/3D ultrasound and elastography for morphometric informations; 
Doppler ultrasound (with its variants) and CEUS allow hemodynamic information. 
CEUS examination is the most specific of them as it is based on different behavior of 
contrast agent transiting liver masses depending on their nature. CEUS accuracy for 
characterization of focal lesions detected on noncirrhotic liver is similar to that of 
CT/MRI, being of 94.5% for metastases, 97% for hemangiomas, and of 90% for focal 
nodular hyperplasia. The method has a performance superior to 2D ultrasound and a 
high rate of diagnosis confidence regardless of the operator in what concerns tumor 
characterization and nodules count (Quaia et al, 2004). 
b. characterization of nodular lesions found on the cirrhotic liver. Ultrasound examination is a 
"screening" procedure used to detect early HCC (Bolondi et al, 2001). The cirrhotic liver 
during the restructuring process develops nodules that often raise questions regarding 
their nature. The criteria used to determine the nature of these nodules involve size, 
circulation pattern (Doppler evaluated) and vascular bed behavior (CEUS evaluated). In 
over 90% of cases, HCC has a characteristic behavior. CEUS exploration has a 
sensitivity of 92-94% and a specificity of 87-96% in characterizing HCC (Tanaka et al, 
2001, Nicolau et al, 2004). 
In a linear study, covering 36 months, (January 2006 – December 2008), made on a cohort of 
379 patients with liver tumors, (fig. 15), we had similar results concerning the performances of 
CEUS compared to other imaging procedures such as CT/MRI and histopathology as other 
groups (personal experience; unpublished results from the project Angiotumor nr. 138/2006 
financed by the Ministry of Education and Research from Romania) (fig. 16) (Badea et al, 2008). 
 
Fig. 15. Types of liver focal lesions diagnosed by CEUS in our study (HCC=hepatocellular 
carcinoma, META=liver metastasis, CCC=cholangiocarcinoma, A-V FIST=arterio-venous 
fistula, FATTY-FREE=fatyy-free area, DISPL NOD=cirrhotic displastic nodule, FNH=focal 
nodular hyperplasia, HEMANG=liver hemangioma) 
c. Detection and characterization of liver metastases. Ultrasound is a method widely used in 
the early detection of liver metastases in patients with cancer pathology. Beyond the 
known limitations of the method, the examination is used because it is accessible, non-
irradiant and it can detect metastases of quite small sizes and allows their 
characterization using vascular criteria. CEUS examination increases the performance of 
conventional ultrasound to values comparable with CT/MRI, becoming an alternative 
to these procedures in certain well defined situations (Dietrich et al, 2006). 
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Fig. 16. The performance of CEUS in our study for the main malignant and benign lesions 
(HCC=hepatocellular carcinoma, META=liver metastasis, HEMANG=liver hemangioma, 
FNH=focal nodular hyperplasia, Se=sensitivity, Sp=specificity, PPV=positive predictive 
value, NPV=negative predictive value) 
d. Assessing therapeutic efficacy. Using the vascular criteria allows the assessment of 
therapeutic efficacy under chemotherapy (Bolondi et al, 2007). Performing an 
interventional procedure (with diagnostic or therapeutic purpose) simultaneously with 
the administration of i.v. CAs increases the procedure’s efficiency by a better 
visualization of the tumor and by correct guidance of the ablation needle in the active 
(vascularized) area of the tumor (Skjoldbye et al, 2002, Lencioni et al, 2004). After 
ablative procedures, or even better in one month after the procedure, the absence of the 
circulation bed in the tumor in arterial phase suggests an effective treatment (Solbiati et 
al, 2004; Vilana et al, 2006, Bartolotta et al, 2008). This principle is also true for 
chemotherapy with antiangiogenic agents. Even under these conditions combination of 
CEUS with i.v. contrast CT examination is required to detect small metastases between 
procedures (Bartolotta et al, 2008). 
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